Aadi Bioscience Announces Planned Leadership Transition
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined...
Source: prnewswire.com
📰 Aadi Bioscience News
Page 11 - Aadi Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aadi Bioscience. Real-time updates on events, politics, business and more.
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...
Source: prnewswire.com
Aadi Bioscience Announces Planned Leadership Transition
LOS ANGELES, Nov. 8, 2022 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision ...
Source: businessinsider.com
Aadi Bioscience to Present at Upcoming Investor Conferences
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
Source: prnewswire.com
Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors
(RTTNews) - Oncology company Mirati Therapeutics, Inc. (MRTX) and biopharmaceutical company Aadi Bioscience, Inc. (AADI) announced Wednesday a cli...
Aadi Bioscience Inc More Such Health News Mirati Therapeutics Inc Mirati Therapeutics Aadi Bioscience
Source: businessinsider.com
Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium
Poster presentation scheduled for October 27, 2022LOS ANGELES, Oct. 12, 2022 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-st...
Comunidad Autonoma De Cataluna Jorge Nieva Shihe Hou Neil Desai Prnewsfoto Aadi Bioscience Marcy Graham
Source: businessinsider.com
Aadi Bioscience Announces $72.5 Million Private Placement Equity Financing
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined...
United States Aadi Biosciences Neil Desai Aadi Bioscience Exchange Commission Prnewswire Aadi Bioscience Inc
Source: prnewswire.com
Aadi Bioscience Announces Participation in Upcoming September Investor Conferences
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Aadi Biosciences Inc Stock Quote | Stock Price for AADI | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
Aadi Bioscience to Report Second Quarter 2022 Results and Corporate Update
/PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...
Aadi Bioscience Company To Host Conference Call Prnewswire Aadi Bioscience Inc Host Conference Call Call Information
Source: prnewswire.com